¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2025-2031³â) :MedCore
Vertebral Compression Fracture Market Size, Share, & Trends Analysis | Global | 2025-2031 | MedCore | Includes: Vertebroplasty and Percutaneous Vertebral Augmentation Markets
»óǰÄÚµå
:
1717652
¸®¼Ä¡»ç
:
iData Research Inc.
¹ßÇàÀÏ
:
2025³â 04¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 72 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°è ôÃß ¾Ð¹Ú °ñÀý(VCF) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 11¾ï ´Þ·¯¸¦ ³Ñ¾ú½À´Ï´Ù.
ÀÌ º¸°í¼´Â µÎ °¡Áö ÁÖ¿ä ºÎ¹®À» ´Ù·ì´Ï´Ù.
°æÇÇÀû ôÃßÁõ´ë¼ú(PVA)
ôÃß ¼ºÇü¼ú
Æ÷ÇÔµÈ ½ÃÀå µ¥ÀÌÅÍ
ÆÇ¸Å ´ë¼ö
Æò±Õ ÆÇ¸Å °¡°Ý(ASP)
½ÃÀå ±Ô¸ð ¹× ¼ºÀå µ¿Çâ
¼ö¼ú °Ç¼ö
½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
2031³â±îÁö ½ÃÀå ¿¹Ãø
2024³â±îÁö ½ÇÀû µ¥ÀÌÅÍ
ÇÕº´°ú Àμö
±â¾÷ ÇÁ·ÎÆÄÀÏ ¹× Á¦Ç° Æ÷Æ®Æú¸®¿À
ÁÖ¿ä °æÀï ºÐ¼®
¼¼°è VCF ½ÃÀå µ¿Çâ
¼ºÀå·üÀº Å©°Ô ´Ù¸£Áö¸¸ Àü Áö¿ª¿¡¼ ½ÃÀå ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù.
¼ºÀå·ü¿¡¼´Â Áßµ¿ÀÌ ¸®µåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
´ÙÀ½À¸·Î ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ µÇ°í ÀÖ½À´Ï´Ù.
ºÏ¹Ì´Â ½ÃÀåÀÇ ¼º¼÷µµ¸¦ ¹Ý¿µÇÏ¿© °¡Àå ³·Àº ¼ºÀå·ü ¿¹ÃøÀÌ µÇ°í ÀÖ½À´Ï´Ù.
¼À¯·´µµ ¸¶Âù°¡Áö·Î ¼º¼÷Çϰí ÀÖ½À´Ï´Ù¸¸, ÀÎÇÁ¶ó°¡ È®½ÇÈ÷ Çϰí Àֱ⠶§¹®¿¡ ¼¼°è Á¦3À§¿¡ ·©Å©µÇ°í ÀÖ½À´Ï´Ù.
¼º¼÷µµ°¡ ³·Àº Áö¿ª ½ÃÀå ¼ºÀåÀº Áø´Ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ¼ö¼ú ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¾×¼¼½º °³¼±¿¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù.
¼¼°è VCF ½ÃÀå Á¡À¯À²
Medtronic
2024³â ½ÃÀå ÀüüÀÇ 50% °¡±îÀ̸¦ Â÷ÁöÇÏ´Â ¼¼°è ½ÃÀåÀÇ ¸®´õ
ºÏ¹Ì¿Í ¼À¯·´¿¡¼ °ÇÑ ¿ìÀ§¼º
KyphX(R) ½Ã½ºÅÛÀ» Á¦°øÇÏ°í ¿©·¯ ±¹°¡¿¡¼ PVA ºÎ¹®À» ¼±µµ
Stryker
VCF ½ÃÀå¿¡¼ ¼¼°è 2À§
Á¦Ç°Àº ´ÙÀ½°ú °°½À´Ï´Ù :
AutoPlex(TM) ½Ã¸àÆ® ¹Í¼ ¹× °ø±Þ ½Ã½ºÅÛ
VertaPlex(TM), VertaPlex HV(TM), SpinePlex(R) »À ½Ã¸àÆ®
iVAS(TM) PVA ½Ã½ºÅÛ
AVAflex dz¼± ½Ã½ºÅÛ ¹× AVAmax(R)
°æÀï»ç¿¡ ºñÇØ ºñ¿ë È¿À²ÀûÀÎ ´ëüǰ°ú »ç¿ë ¿ëÀ̼ºÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.
DePuy Synthes
2024³â ½ÃÁ¡¿¡¼ ¼¼°è Á¦3À§ÀÇ °æÀï ±â¾÷
Á¦Ç° Æ÷Æ®Æú¸®¿À´Â ´ÙÀ½°ú °°½À´Ï´Ù:
CONFIDENCE(TM) ôÃß ½Ã¸àÆ® ½Ã½ºÅÛ
VERTECEM(TM) V »À ½Ã¸àÆ®
ºÏ¹Ì¿Í ¼À¯·´¿¡¼ °ÇÑ Á¸Àç°¨
ÃßüÁõ´ë¼ú¿¡¼ÀÇ Àü´Þ Á¦¾î¿Í ¾ÈÁ¤¼º¿¡ ÁÖ·Â
½ÃÀå ¼¼ºÐÈ ¿ä¾à
ôÃß ¼ºÇü¼ú
°æÇÇÀû ôÃßÁõ´ë¼ú(PVA)
Á¶»ç ¹üÀ§ ¿ä¾à
´ë»ó Áö¿ª
ºÏ¹Ì: ij³ª´Ù, ¹Ì±¹
¶óƾ¾Æ¸Þ¸®Ä« : ¾Æ¸£ÇîÆ¼³ª, º¼¸®ºñ¾Æ, ºê¶óÁú, Ä¥·¹, ÄÝ·Òºñ¾Æ, ÄÚ½ºÅ¸¸®Ä«, µµ¹Ì´ÏÄ« °øÈ±¹, ¿¡Äâµµ¸£, °úÅ׸»¶ó, ¸ß½ÃÄÚ, ÆÄ³ª¸¶, ÆÄ¶ó°úÀÌ, Æä·ç, Ǫ¿¡¸£Å丮ÄÚ, ¿ì·ç°úÀÌ, º£³×¼ö¿¤¶ó
¼À¯·´ : ¿À½ºÆ®¸®¾Æ, º£³×·è½º, ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, Æ÷¸£Åõ°¥, ½ºÄµð³ªºñ¾Æ, ½ºÆäÀÎ, ½ºÀ§½º, ¿µ±¹
ÁßÀ¯·´ ¹× µ¿À¯·´ : ¾ÆÁ¦¸£¹ÙÀÌÀÜ, ¹ßÆ® »ï±¹, º§·Î·ç½Ã, ºÒ°¡¸®¾Æ, Å©·Î¾ÆÆ¼¾Æ, üÄÚ °øÈ±¹, Á¶Áö¾Æ, ±×¸®½º, Çë°¡¸®, Ä«ÀÚÈ彺ź, Æú¶õµå, ·ç¸¶´Ï¾Æ, ·¯½Ã¾Æ, ¼¼¸£ºñ¾Æ, ½½·Î¹ÙŰ¾Æ, ½½·Îº£´Ï¾Æ, Æ¢¸£Å°¿¹, ¿ìÅ©¶óÀ̳ª
Áßµ¿ : ¹Ù·¹ÀÎ, À̶õ, À̽º¶ó¿¤, Äí¿þÀÌÆ®, ¿À¸¸, īŸ¸£, »ç¿ìµð¾Æ¶óºñ¾Æ, ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
¾Æ½Ã¾ÆÅÂÆò¾ç: È£ÁÖ, įº¸µð¾Æ, Áß±¹, È«Äá, Àεµ, Àεµ³×½Ã¾Æ, ÀϺ», ۸£±â½º½ºÅº, ¸¶Ä«¿À, ¸»·¹À̽þÆ, ¸ù°ñ, ¹Ì¾á¸¶, ´ºÁú·£µå, ÆÄŰ½ºÅº, Çʸ®ÇÉ, ½Ì°¡Æ÷¸£, Çѱ¹, ½º¸®¶ûÄ«, ´ë¸¸, ű¹, ¿ìÁŰ½ºÅº, º£Æ®³²
¾ÆÇÁ¸®Ä«: ¾ËÁ¦¸®, ÀÌÁýÆ®, ¿¡Æ¼¿ÀÇǾÆ, °¡³ª, ÄɳÄ, ¸®ºñ¾Æ, ¸ð·ÎÄÚ, ³ªÀÌÁö¸®¾Æ, ³²¾ÆÇÁ¸®Ä«, ¼ö´Ü, ¿ì°£´Ù
±âÁØ¿¬µµ : 2024³â
¿¹Ãø ±â°£ : 2025-2031³â
°ú°Å µ¥ÀÌÅÍ : 2021-2023³â
Á¤·® µ¥ÀÌÅÍ
¼ö¼ú °Ç¼ö
½ÃÀå ±Ô¸ð
½ÃÀå Á¡À¯À²
½ÃÀå ¿¹Ãø
½ÃÀå ¼ºÀå·ü
ÆÇ¸Å ´ë¼ö
Æò±Õ ÆÇ¸Å °¡°Ý
ÁúÀû µ¥ÀÌÅÍ
½ÃÀå ¼ºÀå µ¿Çâ
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
°æÀï ºÐ¼®
ÇÕº´Àμö
±â¾÷ ÇÁ·ÎÆÄÀÏ
Á¦Ç° Æ÷Æ®Æú¸®¿À
FDA ¸®ÄÝ
ÆÄ±«Àû ±â¼ú
µ¥ÀÌÅÍ ¼Ò½º
¾÷°è ¸®´õ¿ÍÀÇ 1Â÷ ÀÎÅͺä
Á¤ºÎ ÀÇ»ç µ¥ÀÌÅÍ
±ÔÁ¦ µ¥ÀÌÅÍ
º´¿ø µ¥ÀÌÅÍ
¼öÃâÀÔ µ¥ÀÌÅÍ
»ç³» µ¥ÀÌÅͺ£À̽º
ÀÌ º¸°í¼´Â ¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ½ÃÀå ºÐ¼®°ú ¿¹Ãø, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ µîÀ» Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
ôÃß ¾Ð¹Ú °ñÀý ½ÃÀå
ÁÖ¿ä ¿ä¾à
°³¿ä : ¼¼°èÀÇ Ã´Ãß ¾Ð¹Ú °ñÀý ½ÃÀå
°æÀï ºÐ¼®
½ÃÀå ¼¼ºÐÈ
´ë»ó Áö¿ª
¼Ò°³
°æÇÇÀû ôÃß ¼ºÇü¼ú
PVA(Ãßü ¼ºÇü¼ú Æ÷ÇÔ)
¼ö±â °Ç¼ö
ÀüôÃ߾йڰñÀý ¼ö¼ú
ôÃß ¼ºÇü¼ú
°æÇÇÀû ôÃßÁõ´ë¼ú
½ÃÀå °³¿ä
½ÃÀå ºÐ¼® ¹× ¿¹Ãø
ÀüôÃ߾йڰñÀý½ÃÀå
ôÃß¼ºÇü¼ú ½ÃÀå
°æÇÇÀû ôÃßÁõ´ë¼ú ½ÃÀå
ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
°æÀï ½ÃÀå Á¡À¯À² ºÐ¼®
JHS
¿µ¹® ¸ñÂ÷
The global VCF market was valued at over $1.1 billion in 2024.
It is projected to grow at a CAGR of 5.2%, reaching over $1.6 billion by 2031.
The report covers two primary segments:
Percutaneous Vertebral Augmentation (PVA)
Vertebroplasty
Market Data Included
Unit Sales
Average Selling Prices (ASPs)
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts to 2031
Historical Data to 2024
Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitor Analysis
Global VCF Market Trends
All regions are projected to experience market growth, though the rate of growth varies significantly:
Middle East is expected to lead in growth rate.
Followed by Africa and Asia-Pacific.
North America has the lowest growth forecast, reflecting market maturity.
Western Europe is similarly mature but ranks third globally due to its strong infrastructure.
Market growth in less mature regions is driven by increased diagnosis, rising elderly populations, and better access to surgical solutions.
Global VCF Market Share Insights
1 Medtronic
Global market leader in 2024, holding close to 50% of the total market value.
Strong dominance in North America and Western Europe.
Offers the KyphX(R) system and leads the PVA segment in multiple countries.
2 Stryker
Ranked second globally in the VCF market.
Products include:
AutoPlex(TM) cement mixer and delivery system
VertaPlex(TM), VertaPlex HV(TM), and SpinePlex(R) bone cements
iVAS(TM) PVA system
AVAflex Balloon System and AVAmax(R)
Known for cost-effective alternatives and ease of use compared to competitors.
3 DePuy Synthes
Third-largest competitor globally in 2024.
Product portfolio includes:
CONFIDENCE(TM) Spinal Cement System
VERTECEM(TM) V+ bone cement
Strong presence in North America and Western Europe.
Focused on controlled delivery and stability in vertebral augmentation procedures.
Market Segmentation Summary
Vertebroplasty
Percutaneous Vertebral Augmentation (PVA)
Research Scope Summary
Regions Covered
North America: Canada, United States
Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
Asia-Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023
Quantitative Data
Procedure Numbers
Market Size
Market Shares
Market Forecasts
Market Growth Rates
Units Sold
Average Selling Prices
Qualitative Data
Market Growth Trends
Market Limiters
Competitive Analysis
Mergers & Acquisitions
Company Profiles
Product Portfolios
FDA Recalls
Disruptive Technologies
Data Sources
Primary Interviews with Industry Leaders
Government Physician Data
Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
TABLE OF CONTENT
Vertebral Compression Fracture Market
9.1 Executive Summary
9.1.1 Global Vertebral Compression Fracture Market Overview
9.1.2 Competitive Analysis
9.1.3 Procedure Segmentation
9.1.4 Market Segmentation
9.1.5 Regions Included
9.2 Introduction
9.2.1 Percutaneous Vertebroplasty
9.2.2 PVA Including Kyphoplasty
9.3 Procedure Numbers
9.3.1 Total Vertebral Compression Fracture Procedures
9.3.2 Vertebroplasty Procedures
9.3.3 Percutaneous Vertebral Augmentation Procedures
9.4 Market Overview
9.4.1 By Segment
9.4.2 By Region
9.5 Market Analysis and Forecast
9.5.1 Total Vertebral Compression Fracture Market
9.5.2 Vertebroplasty Market
9.5.3 Percutaneous Vertebral Augmentation Market
9.6 Drivers and Limiters
9.6.1 Market Drivers
9.6.2 Market Limiters
9.7 Competitive Market Share Analysis
°ü·ÃÀÚ·á